Showing results (91-100 of 110) with videos related to
Sort By:
Pageof 11
The Lancet. Gastroenterology & Hepatology|June 9, 2020
Management of primary hepatic malignancies during the COVID-19 pandemic: recommendations for risk mitigation from a multidisciplinary perspectiveAisling Barry, Smith Apisarnthanarax, Grainne M O'Kane, et al.Journal of Gastroenterology and Hepatology|March 23, 2011
Hepato-biliary clinical trials and their inclusion in the Cochrane Hepato-Biliary Group register and reviewsSarah Louise Klingenberg, Dimitrinka Nikolova, Nicholas Alexakis, et al.Nature Communications|May 15, 2021
Targeting human Acyl-CoA:cholesterol acyltransferase as a dual viral and T cell metabolic checkpointNathalie M Schmidt, Peter A C Wing, Mariana O Diniz, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 22, 2022
Long-Term Outcomes and Exploratory Analyses of the Randomized Phase III BILCAP StudyJohn Bridgewater, Peter Fletcher, Daniel H Palmer, et al.Basic Research in Cardiology|December 3, 2014
Remote ischemic conditioning: from experimental observation to clinical application: report from the 8th Biennial Hatter Cardiovascular Institute WorkshopJack M J Pickard, Hans Erik Bøtker, Gabriele Crimi, et al.The Lancet. Oncology|March 30, 2019
Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 studyJohn N Primrose, Richard P Fox, Daniel H Palmer, et al.Rheumatology (Oxford, England)|August 26, 2025
Coming to a hard stop? Effect of tapered tocilizumab after weekly tocilizumab cessation for giant cell arteritis: a multicentre evaluationVanessa Quick, Stephen Sah, Shirish Dubey, et al.Rheumatology (Oxford, England)|November 12, 2023
Relapse after cessation of weekly tocilizumab for giant cell arteritis: a multicentre service evaluation in EnglandVanessa Quick, Mahdi Abusalameh, Sajeel Ahmed, et al.The British Journal of Surgery|May 18, 2026
Surgical innovation and technologyJeffrey B Matthews, Jelle P Ruurda, Peter G Vaughan-Shaw, et al.Health Technology Assessment (Winchester, England)|February 7, 2018
PET-PANC: multicentre prospective diagnostic accuracy and health economic analysis study of the impact of combined modality 18fluorine-2-fluoro-2-deoxy-d-glucose positron emission tomography with computed tomography scanning in the diagnosis and management of pancreatic cancerPaula Ghaneh, Robert Hanson, Andrew Titman, et al.Pageof 11